Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

40
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
40
Hemodialysis III: Nursing Management01:25

Hemodialysis III: Nursing Management

217
The nursing management of a patient undergoing hemodialysis includes several critical steps, starting with a thorough assessment before the procedure.Before the Hemodialysis ProcedureFirst, record the patient's vital signs—blood pressure, heart rate, respiratory rate, and temperature—to establish a baseline. This baseline is essential for detecting conditions such as hypotension that could impact the patient's response to dialysis. Document the patient's pre-dialysis weight, as this...
217
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

62
Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
62
Acute Kidney Injury VI: Nursing Management01:22

Acute Kidney Injury VI: Nursing Management

71
Acute Kidney Injury (AKI) results in an inability to maintain fluid, electrolyte, and acid-base balance. Effective nursing management is critical in improving patient outcomes and includes comprehensive patient assessment and targeted interventions.Comprehensive Patient AssessmentA detailed history collection is essential, focusing on any recent infections, nephrotoxic medication use, or chronic conditions such as hypertension and diabetes that may contribute to AKI. During the physical...
71
Enteral Nutrition II: Nasointestinal and Gastrostomy Feeding01:15

Enteral Nutrition II: Nasointestinal and Gastrostomy Feeding

310
Enteral nutrition encompasses various methods of delivering nutrition directly to the gastrointestinal (GI) tract, bypassing traditional oral intake. It is particularly beneficial for patients who cannot eat by mouth but have a functioning digestive system. Key methods include nasointestinal feeding, gastrostomy, and jejunostomy, each suited to different clinical scenarios based on the patient's needs and condition.
Nasointestinal Feeding
Nasointestinal feeding involves placing a tube...
310
Heart Failure VII: Nursing Interventions01:30

Heart Failure VII: Nursing Interventions

149
The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
149

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

From Points to Landscapes: Measuring and Scaling Up Methane Emissions From Mound-Building Termites.

Global change biology·2026
Same author

Re: Interpreting the cost-effectiveness of diabetes remission programmes beyond the durability of remission.

Diabetic medicine : a journal of the British Diabetic Association·2026
Same author

<i>Supportive Care in What</i>? Myths and Misconceptions That Prevent the Provision of Excellent Cancer Care.

JCO global oncology·2026
Same author

Bridging prediction and reality: AI-based external validation of predictive models for lymph node metastasis in gastric cancer.

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·2026
Same author

"Am I too old for a shoulder replacement?" The association between age and comorbidities on the outcomes following Reverse Shoulder Arthroplasty.

Journal of shoulder and elbow surgery·2026
Same author

Evaluating a Train-the-Trainer program to implement a navigation program for older people with cancer across six European countries, as part of the EU NAVIGATE project: a Kirkpatrick multi-method evaluation.

BMC health services research·2026

Related Experiment Video

Updated: Sep 20, 2025

A Novel Approach for the Administration of Medications and Fluids in Emergency Scenarios and Settings
06:59

A Novel Approach for the Administration of Medications and Fluids in Emergency Scenarios and Settings

Published on: November 9, 2016

30.6K

Clinically assisted hydration in advanced cancer.

Andrew Davies1

  • 1Professor of Palliative Medicine, Trinity College Dublin, University College Dublin, Our Lady's Hospice & Care Services, Dublin, Ireland.

Current Opinion in Supportive and Palliative Care
|May 23, 2025
PubMed
Summary

Clinically assisted hydration (CAH) in advanced cancer patients is controversial. Limited, low-quality evidence exists, but new expert guidance aids decision-making for end-of-life care.

Keywords:
clinically assisted hydrationneoplasmspalliative care

More Related Videos

Percutaneous Hepatic Perfusion PHP with Melphalan as a Treatment for Unresectable Metastases Confined to the Liver
09:02

Percutaneous Hepatic Perfusion PHP with Melphalan as a Treatment for Unresectable Metastases Confined to the Liver

Published on: July 31, 2016

12.1K
Isolated Hepatic Perfusion as a Treatment for Liver Metastases of Uveal Melanoma
09:52

Isolated Hepatic Perfusion as a Treatment for Liver Metastases of Uveal Melanoma

Published on: January 25, 2015

13.5K

Related Experiment Videos

Last Updated: Sep 20, 2025

A Novel Approach for the Administration of Medications and Fluids in Emergency Scenarios and Settings
06:59

A Novel Approach for the Administration of Medications and Fluids in Emergency Scenarios and Settings

Published on: November 9, 2016

30.6K
Percutaneous Hepatic Perfusion PHP with Melphalan as a Treatment for Unresectable Metastases Confined to the Liver
09:02

Percutaneous Hepatic Perfusion PHP with Melphalan as a Treatment for Unresectable Metastases Confined to the Liver

Published on: July 31, 2016

12.1K
Isolated Hepatic Perfusion as a Treatment for Liver Metastases of Uveal Melanoma
09:52

Isolated Hepatic Perfusion as a Treatment for Liver Metastases of Uveal Melanoma

Published on: January 25, 2015

13.5K

Area of Science:

  • Palliative Care
  • Oncology
  • Clinical Hydration Therapy

Background:

  • The use of clinically assisted hydration (CAH) in advanced cancer patients, particularly near end of life, is a contentious issue.
  • Existing literature on CAH in this population is limited and often of low quality.
  • Concerns exist regarding the adequacy of fluid administration in prior studies.

Purpose of the Study:

  • To review recent developments concerning CAH in patients with advanced cancer.
  • To synthesize current evidence and expert consensus on this controversial intervention.

Main Methods:

  • Literature review of recent developments in CAH for advanced cancer.
  • Analysis of the quality and volume of new evidence.
  • Consideration of expert consensus guidelines.

Main Results:

  • A low volume of new literature was identified.
  • The quality of the available evidence regarding CAH is generally low.
  • Adequacy of fluid therapy in previous studies is questionable.

Conclusions:

  • There is currently insufficient evidence to definitively guide clinical practice for CAH in advanced cancer.
  • New expert consensus guidance from the Multinational Association of Supportive Care in Cancer (MASCC) is available to support clinical decision-making.
  • Further high-quality research is needed to inform best practices.